Data / Form D filings / Twist Bioscience Corp
Twist Bioscience Corp: Form D filings
Twist Bioscience Corp, a biotechnology company in San Francisco, CA, filed 11 Form D notices with the SEC between 2013 and 2018. The latest, on April 2, 2018, reports $50 million sold of a $85 million offering to 1 investor.
Find out what Twist Bioscience Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 455 MISSION BAY BOULEVARD SOUTH, SUITE 545, San Francisco, CA, 94158
- Phone
- (800) 719-0671
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1581280
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2018 | New notice | $85,000,000 | $50,000,000 | $35,000,000 | 1 | Mar 19, 2018 | sec.gov |
| Dec 29, 2017 | Amendment | $75,000,000 | $74,949,996 | $50,004 | 63 | Mar 9, 2017 | sec.gov |
| Jun 14, 2017 | Amendment | $63,183,691 | $60,348,704 | $2,834,987 | 47 | Mar 9, 2017 | sec.gov |
| May 18, 2017 | Amendment | $50,000,000 | $49,310,751 | $689,249 | 44 | Mar 9, 2017 | sec.gov |
| Mar 27, 2017 | New notice | $33,197,668 | $32,196,141 | $1,001,527 | 28 | Mar 9, 2017 | sec.gov |
| Apr 19, 2016 | New notice | $2,650,000 | $2,650,000 | $0 | 46 | Apr 5, 2016 | sec.gov |
| Jan 20, 2016 | New notice | $61,047,413 | $61,047,413 | $0 | 35 | Jan 8, 2016 | sec.gov |
| Jun 11, 2015 | New notice | $36,999,999 | $36,999,999 | $0 | 28 | May 29, 2015 | sec.gov |
| May 28, 2014 | New notice | $26,500,001 | $25,999,999 | $500,002 | 24 | May 13, 2014 | sec.gov |
| Feb 10, 2014 | Amendment | $9,298,571 | $9,110,714 | $187,857 | 16 | Jul 1, 2013 | sec.gov |
| Jul 12, 2013 | New notice | $9,010,714 | $4,748,811 | $4,261,903 | 14 | Jul 1, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keith Marine Crandell | Director | |
| Paul Marine Conley | Director | |
| Bob Marine Ragusa | Director | |
| Minqi Marine Li | Director | |
| Rob Marine Chess | Director | |
| William Marine Banyai | Executive Officer, Director | |
| Fred Marine Craves | Director | |
| Bill Marine Peck | Executive Officer | |
| Emily Marine Leproust | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Apr 2, 2018 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Twist Bioscience Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.